Updated 02:01 GMT, 16 Nov 2026 SPX 7,561.67 -0.40% NDX 27,943.74 -1.22% VIX 19.30 +3.21% GOLD 3,876.40 -0.25% CL 88.33 -0.26% BTC 64,613.34 +0.76%
NAS100 27,944 −1.22% S&P 7,562 −0.40% GOLD $3,876 −0.25% BTC $64,613 +0.76% VIX 19.30 +3.21% latest tape · as of 02:01 UTC
The Screen · Financials · Capital Markets

Cango Inc

CANG · the NYSE · USD · Market cap $117M · 96 employees

Cango Inc.

FAIL · Does not pass the screen
3.81 USD

Price as of 15 Oct 2026Daily close, not a live quoteLast reviewed 32 days ago

Screened 2026-10-15 · the tape above runs as of 02:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price3.81 USD at the 15 Oct 2026 close
  • Fair valueUnder review: its inputs are 31 days old.
  • Our regime readDistribution, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • Last reviewed15 Oct 2026 (32 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: range not available (screen dated 2026-10-15).

Current read
Distribution ?
Screened · screened 2026-10-15
  • Trend Distribution
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price3.81 USD
Fair valueUnder review
Ethical score30.0/100
Our investment reviews on this name
2026-11-04Read Distribution3.81+0.0% to today Markup gives way to Distribution after a 1242% rise in 10 weeks
2026-08-24Read Markup0.28+1,241.5% to today ✓Distribution gives way to Markup
2026-07-02Read Distribution0.28+1,241.5% to today First review on file: Distribution

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

Cango Inc holds its Distribution at $3.81. Elevated stress, defensive posture warranted, held for 65 days.

As held on the ledger · 2026-10-15
PhaseDistribution · caution
Quantitative stateElevated stress, defensive posture warranted, held for 65 days
Price at the screen$3.81
ValuationN/A trailing · 32.57 forward price to earnings
Values screenFAIL · score 30.0
The Workings

Five Screens, Shown in Full

Does not pass. Excluded industry: Capital Markets

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Excluded industry: Capital Markets Fail
Debt load Excluded Below 33% Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash Excluded Below 33% Interest-bearing cash and securities are of assets, above the one-third limit. Fail
Receivables Excluded Below 49% Money owed to the company is of assets, above the 49% limit. Fail
Revenue purity Excluded Below 5% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Cango does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.

Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when CANG's ethical verdict changes

Today CANG does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Fair value under review. Its inputs are 31 days old. We show no fair value, margin of safety or value read built on it until the review clears.

How a fair value is estimated: discounted cash flow (DCF).

Price History & Projections

Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-10-15 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words
The fundamentals · plain-English read
Forward P/E32.6xa premium valuation
EPS, trailing-2.19
EPS, forward0.07
Revenue growth-33.2%revenue is shrinking
Profit margin-131.7%currently unprofitable
Return on equity-177.7%not currently earning a positive return on equity
Debt to equity0.16minimal debt: a conservative balance sheet
52-week range0.28 - 2.88
MoatNONE
Market cap$117M
Employees96

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

CANG trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-15 Distribution $3.81 +0.0% Entry 10

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 25% above its long-term trend line with momentum reading oversold. Over the past year the shares are down 88%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (2 analysts) rates it strong buy, with a mean price target of $3.

2026-11-04 Distribution · changed $3.81 +0.0% Entry 9

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 37% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 88%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (2 analysts) rates it strong buy, with a mean price target of $3.

2026-10-28 Markup $3.81 +8.5% Entry 8

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 8.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 37% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 88%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (2 analysts) rates it strong buy, with a mean price target of $3.

2026-10-14 Markup $3.51 +53.9% Entry 7

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 53.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 88%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (2 analysts) rates it strong buy, with a mean price target of $3.

2026-10-02 Markup $2.28 +702.8% Entry 6

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 702.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 88%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (2 analysts) rates it strong buy, with a mean price target of $3. Since the last review it its composite score eased.

2026-08-24 Markup · changed $0.28 +0.0% Entry 5

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 88%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (2 analysts) rates it strong buy, with a mean price target of $3.

2026-07-24 Distribution $0.28 +0.0% Entry 4

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 88%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (2 analysts) rates it strong buy, with a mean price target of $3.

2026-07-18 Distribution $0.28 +0.0% Entry 3

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 88%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (2 analysts) rates it strong buy, with a mean price target of $3.

2026-07-03 Distribution $0.28 +0.0% Entry 2

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.

2026-07-02 Distribution $0.28 Entry 1

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $0.65 -51.6% · $485 -51.6%
2 months $0.44 -28.4% · $716 -28.4%
3 months $0.59 -46.6% · $534 -46.6%
6 months $1.22 -74.2% · $258 -74.2%
1 year $2.57 -87.7% · $123 -87.7%
2 years $0.80 -60.6% · $394 -60.6%
3 years $0.60 -47.5% · $525 -47.5%
5 years $0.85 -63.0% $1.50 $2,135 +113.5%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever CANG does next, these words stay.

Cango Inc · CANG · Distribution · $3.81
Recorded 2026-10-15 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.